AwesomeCapital
Search This Blog
Monday, August 5, 2019
AcelRx started at Outperform by Credit Suisse
Target $7
https://www.benzinga.com/stock/ACRX/ratings
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.